Table 1.
Summary characteristics of patients
| Characteristics Freq (%) | Intervention (n = 3010) | Control (n = 1958) | Total (n = 4968) | |
|---|---|---|---|---|
| Sex | Male | 1630 (54.2) | 1018 (52.0) | 2648 (53.3) |
| Age group (years) | 18-39 | 52 (1.7) | 21 (1.1) | 73 (1.5) |
| 40-49 | 199 (9.6) | 109 (5.6) | 308 (6.2) | |
| 50-59 | 573 (19.0) | 335 (17.1) | 908 (18.3) | |
| 60-69 | 1015 (33.7) | 604 (30.8) | 1619 (32.6) | |
| 70-79 | 867 (28.8) | 680 (34.7) | 1547 (31.1) | |
| 80+ | 304 (10.1) | 209 (10.7) | 513 (10.3) | |
| Age (years) median (IQ range) | 66.0 (59.0-74.0) | 68.0 (60.0-75.0) | 67.0 (59.0-75.0) | |
| Geographic region | Urban | 897 (29.8) | 840 (42.9) | 1737 (35.0) |
| Rural | 917 (30.5) | 447 (22.8) | 1364 (27.5) | |
| Remote | 1196 (39.7) | 671 (34.3) | 1867 (37.6) | |
| Condition* | Anticoagulant therapy | 572 (19.0) | 372 (19.0) | 944 (19.0) |
| Diabetes | 1182 (39.3) | 785 (40.1) | 1967 (39.6) | |
| Hyperlipidaemia | 2356 (78.3) | 1463 (74.7) | 3819 (76.9) |
*Patients could have more than one condition